BioNxt Solutions Inc.
BNXT
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -52.04% | -63.77% | -29.35% | 7.53% | 8.87% |
| Total Depreciation and Amortization | -75.00% | -71.83% | -88.08% | -74.39% | -66.54% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 131.45% | 123.56% | 96.13% | 48.40% | 66.78% |
| Change in Net Operating Assets | -332.98% | -1,195.43% | -221.09% | -175.04% | -63.51% |
| Cash from Operations | -35.95% | -34.79% | -68.34% | -55.33% | 20.35% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 72.51% | -9.18% | 136.74% | -64.07% | -77.48% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 11.30% | -45.81% | 48.42% | -71.04% | -70.54% |
| Total Debt Issued | -77.27% | -77.27% | 119.92% | -- | -- |
| Total Debt Repaid | 100.00% | 100.00% | -65.30% | -29,376.34% | -14,717.84% |
| Issuance of Common Stock | 559.16% | 141.46% | 40.52% | -22.41% | -82.88% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 49.67% | 77.46% | -42.84% | -193.15% | -48.18% |
| Cash from Financing | 91.52% | 19.66% | 90.90% | 118.06% | -24.21% |
| Foreign Exchange rate Adjustments | -46.67% | -70.59% | 0.00% | -60.71% | 66.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 467.93% | -232.24% | 105.18% | 171.61% | -719.93% |